Iscom-like nanoparticles formulated with quillaja brasiliensis saponins are promising adjuvants for seasonal influenza vaccines

HIGHLIGHTS

• who: Mariana Rivera-Patron and colleagues from the Departamento de Desarrollo Biotecnológico, Instituto de Higiene, Facultad de Medicina, Universidade Federal da Paraíba, Cidade Universitária, João Pessoa, Brazil have published the research work: ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines, in the Journal: Vaccines 2021, x of 18/Nov/2021
• what: The authors demonstrate that a split-inactivated IQB90 adjuvanted vaccine triggered a protective immune response stronger than that induced by a commercial unadjuvanted vaccine when applied either by the subcutaneous or the intranasal . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.